Skip to main content
. Author manuscript; available in PMC: 2012 Mar 1.
Published in final edited form as: Hepatology. 2011 Feb 11;53(3):810–820. doi: 10.1002/hep.24127

Table 8.

Regression analysis of liver enzymes and measures of metabolic syndrome and insulin resistance on livery histology (NAS≥5 and NASH diagnosis)

ALT (U/L)

Models β 95% CI P
One variable model
    NAS≥5 30.9 23.0 – 38.8 <0.0001
    NASH diagnosis 25.5 17.3 – 33.7 <0.0001
Two variable models
    NAS≥5 24.5 15.1 – 34.0 <0.0001
    NASH Dx 11.8 2.1 – 21.3 0.02

AST (U/L)

Models β 95% CI P

One variable model
    NAS≥5 25.9 20.2 – 31.7 <0.0001
    NASH diagnosis 25.7 19.8 – 31.6 <0.0001
Two variable models
    NAS≥5 17.3 10.4 – 24.1 <0.0001
    NASH Dx 16.1 9.1 – 23.0 <0.0001

Diabetes

Models OR 95% CI P

One variable model
    NAS≥5 1.33 0.99 – 1.79 0.06
    NASH diagnosis 1.92 1.41 – 2.62 <0.0001
Two variable models
    NAS≥5 0.90 0.63 – 1.29 0.58
    NASH Dx 2.04 1.40 – 2.96 <0.0001

Metabolic Syndrome

Models OR 95% CI P

One variable model
    NAS≥5 1.21 0.93 – 1.58 0.16
    NASH diagnosis 1.43 1.09 – 1.98 0.009
Two variable models
    NAS≥5 0.98 0.71 – 1.36 0.91
    NASH Dx 1.45 1.04 – 2.01 0.03

HOMA-IR

Models β 95% CI P

One variable model
    NAS≥5 1.39 0.48 – 2.31 0.003
    NASH diagnosis 1.70 0.77 – 2.62 <0.0001
Two variable models
    NAS≥5 0.68 −0.41 – 1.77 0.22
    NASH Dx 1.32 0.21 – 2.42 <0.0001

QUICKI (X 1,000 )

Models β 95% CI P

One variable model
    NAS≥5 −7.17 −12.49 – −1.85 0.008
    NASH diagnosis −9.24 −14.63 – −3.86 0.001
Two variable models
    NAS≥5 −3.12 −9.45 – −3.86 0.33
    NASH Dx −7.51 −13.95 – −1.06 0.02